?1 prior routine of chemotherapy for Highly developed breast cancer and over the full trial, prior exposure to any FGFR inhibitor, big medical procedures or radiotherapy in just 4 weeks previous to to start with dose of study treatment method and taking potent inhibitors or inducers of CYP3A4 or CYP2D6. Any of the following cardiac requirements pre